no image available Dickens & Co. "Breaking Barriers in Cancer Treatment: The Promise of Bendamustin-Rituximab Combination Therapy for CLL Patients" "Unveiling the Hope of Improved Outcomes and Enhanced Quality of Life for those Affected by Chronic Lymphocytic Leukemia" Price: 28.00€